2006. "Diagnosing with Feeling: The Clinical Assessment of Schizophrenia in early Twentieth Century European Psychiatry." In Emotions, Medicine and Disease, 1750-1950, edited by Fay Bound Alberti, 169-190. New York: Palgrave Macmillan.Lanzoni, S. (2006) `Diagnosing with Feeling: The Clinical ...
SchizophreniaFactor structureValidityThis study aimed to examine the validity of the Clinical Assessment Interview for Negative Symptoms (CAINS) in Singapore. 274 participants with schizophrenia were assessed on the CAINS, Scale for the Assessment of Negative Symptoms (SANS), Positive and Negative ...
DH4: SCHIZOPHRENIA CARE AND ASSESSMENT PROGRAM (SCAP): IMPACT OF CLINICAL AND FUNCTIONAL STATUS AND TYPE OF MEDICATION TREATMENT ON OUTPATIENT PSYCHIATRIC ... PRD Smith - 《Value in Health》 被引量: 0发表: 2000年 SCHIZOPHRENIA CARE AND ASSESSMENT PROGRAM (SCAP): IMPACT OF CLINICAL AND ...
也就是，大部分临床心理学博士生在医疗系统里做住院实习，而大部分咨询心理学博士生在社区的咨询中心里...
A review of the clinical suicidology literature suggests the importance of 3 key domains in the assessment of suicide risk: those of Mental state, Affective state, and Psychosocial context (MAP). The most important database for suicide risk assessment is the client's mental state and intention ...
Clinical Assessment Workbook: Balancing Strengths and Differential Diagnosis, 2nd Edition1. Introduction. 2. Infant, Childhood and Adolescent Disorders. 3. Cognitive Disorders and Neurological Disorders Due to a Medical Condition. 4. Alcohol and Drug-Related Disorders. 5. Schizophrenia and Other ...
Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia - ScienceDirect This study examined the clinical utility of the Negative Symptom Assessment-16 (NSA-16) in schizophrenia. 274 individuals with schizophrenia were assessed ... GR A,LA B,SAA Mei,... - 《Europe...
The recruited patients are receiving 265 mg ALZ-801 or placebo twice daily for 18 months. The trial started in May 2021. The primary endpoint is ADAS-Cog scores, and the secondary endpoints are scores of the Disability Assessment for Dementia, CDR-SB, and Amsterdam-iADL. The biomarkers of ...
A cross-sectional assessment of a randomly selected cohort of patients (n=225; mean age=42±7 years; mean length of illness=20.4±7.5 years) with DSM-IV schizophrenia was employed using standard rating instruments for catatonia, drug-induced extrapyramidal symptoms (EPS), and psychotic, ...
Assessing negative symptoms in schizophrenia: validity of the clinical assessment interview for negative symptoms in Singapore. Schizophr. Res. 206, 177–182 (2019). Article PubMed Google Scholar Strauss, G. P. et al. Factor structure of the Brief Negative Symptom Scale. Schizophr. Res. 142,...